Core Viewpoint - Minsheng Health's stock experienced a slight decline of 0.58% on October 17, with a trading volume of 39.39 million yuan, indicating a stable market presence despite minor fluctuations [1]. Financing Summary - On October 17, Minsheng Health had a financing buy-in amount of 4.92 million yuan, with a net financing buy of 1.80 million yuan after repayments [1]. - The total financing and securities balance reached 99.86 million yuan, accounting for 6.62% of the circulating market value, which is above the 70th percentile of the past year, indicating a high level of financing activity [1]. - There were no securities sold or repaid on the same day, with a total securities balance of 0.00 yuan, also reflecting a high percentile position [1]. Company Performance - As of June 30, the number of shareholders for Minsheng Health was 21,500, a decrease of 0.41%, while the average circulating shares per person increased by 0.41% to 5,137 shares [2]. - For the first half of 2025, Minsheng Health reported a revenue of 462 million yuan, representing a year-on-year growth of 16.37%, and a net profit attributable to shareholders of 82.41 million yuan, up 6.65% year-on-year [2]. Dividend and Shareholding - Since its A-share listing, Minsheng Health has distributed a total of 71.20 million yuan in dividends [3]. - As of June 30, 2025, Hong Kong Central Clearing Limited was the third-largest circulating shareholder, holding 1.71 million shares, an increase of 714,100 shares compared to the previous period [3].
民生健康10月17日获融资买入492.36万元，融资余额9986.29万元